Release Date: 04/12/18 12:19 Summary: Annual Resource and Reserve Statement Update Price Sensitive: Yes Download Document 724.23KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%